Literature DB >> 19879666

Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons.

Lotte Gerritsen1, Hannie C Comijs, Dorly J H Deeg, Brenda W J H Penninx, Mirjam I Geerlings.   

Abstract

OBJECTIVE: We determined whether salivary cortisol levels were associated with cognitive decline at follow-up in older persons and whether this association was modified by the APOE-ε4 allele.
METHODS: Within the Longitudinal Aging Study Amsterdam (LASA), a population-based prospective cohort study, 911 persons (74.5±7.2 years, 46.4% male) collected salivary cortisol in the morning and late in the evening. At baseline and after 4 years of follow-up, global cognitive functioning, verbal memory performance, and processing speed were assessed. The longitudinal associations between cortisol measures and cognitive decline were estimated using linear mixed models, adjusted for potential confounders and the modifying role of the APOE-ε4 allele was examined.
RESULTS: Lower morning cortisol levels, higher evening cortisol levels, and flattened diurnal variability of cortisol levels were associated with increased risk for memory decline in APOE-ε4 carriers but not in non-carriers.
CONCLUSION: Our findings suggest that in this older non-demented population APOE-ε4 carriers may be more vulnerable to the potential detrimental effect of hypothalamic-pituitary-adrenal axis dysfunction on verbal memory performance.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879666     DOI: 10.1016/j.neurobiolaging.2009.09.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.

Authors:  Eric J Lenze; David Dixon; Rose C Mantella; Peter M Dore; Carmen Andreescu; Charles F Reynolds; John W Newcomer; Meryl A Butters
Journal:  Int J Geriatr Psychiatry       Date:  2011-06-17       Impact factor: 3.485

2.  Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.

Authors:  Davide Bruno; Jay J Nierenberg; James C Ritchie; Michael W Lutz; Nunzio Pomara
Journal:  Psychoneuroendocrinology       Date:  2011-07-30       Impact factor: 4.905

3.  Associations between cognitive function and naturally occurring daily cortisol during middle adulthood: timing is everything.

Authors:  Robert S Stawski; David M Almeida; Margie E Lachman; Patricia A Tun; Christopher B Rosnick; Teresa Seeman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

Review 4.  Mechanisms of cortisol - Substance use development associations: Hypothesis generation through gene enrichment analysis.

Authors:  Kristine Marceau; Emily A Abel
Journal:  Neurosci Biobehav Rev       Date:  2018-05-23       Impact factor: 8.989

5.  Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: results from a pilot study with mifepristone.

Authors:  Eric J Lenze; Tamara Hershey; John W Newcomer; Jordan F Karp; Daniel Blumberger; Jennifer Anger; Peter Doré; David Dixon
Journal:  Int J Geriatr Psychiatry       Date:  2014-03-14       Impact factor: 3.485

6.  The cortisol awakening response and cognition across the adult lifespan.

Authors:  Gilda E Ennis; Scott D Moffat; Christopher Hertzog
Journal:  Brain Cogn       Date:  2016-04-20       Impact factor: 2.310

7.  Interaction of APOE genotype and testosterone on episodic memory in middle-aged men.

Authors:  Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

8.  Age differences in the relationship between cortisol and emotional memory.

Authors:  Angela Gutchess; Alana N Alves; Laura E Paige; Nicolas Rohleder; Jutta M Wolf
Journal:  Psychol Aging       Date:  2019-06-10

9.  ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.

Authors:  Lance A Johnson; Damian G Zuloaga; Erin Bidiman; Tessa Marzulla; Sydney Weber; Helane Wahbeh; Jacob Raber
Journal:  Neuropsychopharmacology       Date:  2015-05-10       Impact factor: 7.853

10.  Volunteering, polygenic risk for Alzheimer's disease, and cognitive functioning among older adults.

Authors:  Sae Hwang Han; J Scott Roberts; Jan E Mutchler; Jeffrey A Burr
Journal:  Soc Sci Med       Date:  2020-04-02       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.